Xia Zhang

Dr. Xia Zhang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
XDXin Ding
Xin Ding
CFChen Fang
Chen Fang
XLXiang Li
Xiang Li
YCYongjun Cao
Yongjun Cao
QZQilin Zhang
Qilin Zhang
XZXia Zhang
Xia Zhang
To compare neurocognitive functioning of Type 1 diabetic mellitus (T1DM) and healthy adults, and explore risk factors of cognitive dysfunction of T1DM patients, especially the association between cognitive impairment and diabetic peripheral neuropathy (DPN). Seventy T1DM (age: 32.17 ± 9.57 yr., duration: 8.99 ± 7.02 yr) patients and 48 healthy volunteers were included. All subjects received evaluation of MMSE and MoCA scales. Cognitive function of T1DM patients was evaluated in different cognitive domains. Risk factors affecting cognitive function were further explored. Three patients with educational level ≤ 6-year were excluded from final analysis. Scores of both MMSE (28.4 ± 1.7 vs. 29.1 ± 1.0, P = 0.005) and MoCA scales (25.9 ± 2.7 vs.27.1 ± 2.4, P = 0.017) in T1DM group were lower than that in control group. For MMSE scale, scores of orientation (9.60 ± 0.79 vs.9.87 ± 0.39, P < 0.001) and language function (8.56 ± 0.65 vs.8.83 ± 0.38, P < 0.001) in T1DM groups were lower than that in control group. For MoCA scale, scores of attention and concentration (2.30 ± 0.74 vs.2.57 ± 0.58, P < 0.001), visuospatial/executive function (4.32 ± 0.91 vs.4.64 ± 0.63, P < 0.001), memory (2.96 ± 1.50 vs.3.66 ± 1.28, P < 0.001), language function (5.71 ± 0.69 vs.5.87 ± 0.39, P = 0.007), and abstraction (1.55 ± 0.68 vs.1.82 ± 0.42, P < 0.001) were lower in T1DM group than that in control group. Logistic regression showed age, fasting C peptide, educational level and nerve conduction velocity (NCV) were associated with cognitive dysfunction diagnosed by MoCA scores for the patients with type 1 diabetes. T1DM adults had mild to moderate cognitive impairment, mainly presenting as dysfunctions of attention and concentration, visuospatial/executive, language, and abstraction. In addition to age, fasting C peptide level, and educational level, DPN, as a diabetic complication, was identified to be associated with cognitive impairments.

1 August 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
YZYafang Zhu
Yafang Zhu
XZXia Zhang
Xia Zhang
SYShoujiang You
Shoujiang You
XCXiaowei Cao
Xiaowei Cao
XWXuan Wang
Xuan Wang
RSRongfang Shi
Rongfang Shi

9 November 2020 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
DMDanyang Meng
Danyang Meng
XMXiaohua Ma
Xiaohua Ma
HLHui Li
Hui Li
XWXuechun Wu
Xuechun Wu
YCYongjun Cao
Yongjun Cao
XZXia Zhang
Xia Zhang

18 July 2018 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
DWDongxing Wang
Dongxing Wang
BHBo Hu
Bo Hu
YDYongping Dai
Yongping Dai
JSJing Sun
Jing Sun
ZLZhaoxia Liu
Zhaoxia Liu
XZXia Zhang
Xia Zhang

13 May 2019 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
XWXuechun Wu
Xuechun Wu
WZWei Zhang
Wei Zhang
HLHui Li
Hui Li
SYShoujiang You
Shoujiang You
JSJijun Shi
Jijun Shi
XZXia Zhang
Xia Zhang

13 September 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YWYi Wang
Yi Wang
DPDan Peng
Dan Peng
YHYaqian Huang
Yaqian Huang
YCYongjun Cao
Yongjun Cao
HLHui Li
Hui Li
XZXia Zhang
Xia Zhang
Podoplanin is a small mucin-like glycoprotein involved in several physiological and pathological processes in the brain including development, angiogenesis, tumors, ischemic stroke and other neurological disorders. Podoplanin expression is upregulated in different cell types including choroid plexus epithelial cells, glial cells, as well as periphery infiltrated immune cells during brain development and neurological disorders. As a transmembrane protein, podoplanin interacts with other molecules in the same or neighboring cells. In the past, a lot of studies reported a pleiotropic role of podoplanin in the modulation of thrombosis, inflammation, lymphangiogenesis, angiogenesis, immune surveillance, epithelial mesenchymal transition, as well as extracellular matrix remodeling in periphery, which have been well summarized and discussed. Recently, mounting evidence demonstrates the distribution and function of this molecule in brain development and neurological disorders. In this review, we summarize the research progresses in understanding the roles and mechanisms of podoplanin in the development and disorders of the nervous system. The challenges of podoplanin-targeted approaches for disease prognosis and preventions are also discussed.